137 related articles for article (PubMed ID: 38461555)
1. Exploring novel pyrazole-nitroimidazole hybrids: Synthesis and antiprotozoal activity against the human pathogen trichomonas vaginalis.
Silva RC; De Freitas A; Vicente B; Midlej V; Dos Santos MS
Bioorg Med Chem; 2024 Mar; 102():117679. PubMed ID: 38461555
[TBL] [Abstract][Full Text] [Related]
2. Effects of SQ109 on Trichomonas vaginalis.
de Souza TG; Granado R; Benaim G; de Souza W; Benchimol M
Exp Parasitol; 2023 Jul; 250():108549. PubMed ID: 37196704
[TBL] [Abstract][Full Text] [Related]
3.
Ghosh AP; Aycock C; Schwebke JR
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29439963
[TBL] [Abstract][Full Text] [Related]
4. Chlorinated metronidazole as a promising alternative for treating trichomoniasis.
Chacon MO; Fonseca THS; Oliveira SBV; Alacoque MA; Franco LL; Tagliati CA; Cassali GD; Campos-Mota GP; Alves RJ; Capettini LSA; Gomes MA
Parasitol Res; 2018 May; 117(5):1333-1340. PubMed ID: 29502297
[TBL] [Abstract][Full Text] [Related]
5. The effect of 3-(biphenyl-4-yl)-3-hydoxyquinuclidine (BPQ-OH) and metronidazole on Trichomonas vaginalis: a comparative study.
Rocha DA; de Andrade Rosa I; Urbina JA; de Souza W; Benchimol M
Parasitol Res; 2014 Jun; 113(6):2185-97. PubMed ID: 24752367
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in
Graves KJ; Novak J; Secor WE; Kissinger PJ; Schwebke JR; Muzny CA
Parasitology; 2020 Nov; 147(13):1383-1391. PubMed ID: 32729451
[TBL] [Abstract][Full Text] [Related]
7. Effects of amiodarone, amioder, and dronedarone on Trichomonas vaginalis.
de Souza TG; Benaim G; de Souza W; Benchimol M
Parasitol Res; 2022 Jun; 121(6):1761-1773. PubMed ID: 35435511
[TBL] [Abstract][Full Text] [Related]
8. Promising hit compounds against resistant trichomoniasis: Synthesis and antiparasitic activity of 3-(ω-aminoalkoxy)-1-benzyl-5-nitroindazoles.
Ibáñez-Escribano A; Reviriego F; Vela N; Fonseca-Berzal C; Nogal-Ruiz JJ; Arán VJ; Escario JA; Gómez-Barrio A
Bioorg Med Chem Lett; 2021 Apr; 37():127843. PubMed ID: 33556576
[TBL] [Abstract][Full Text] [Related]
9. Antiparasitic activity of furanyl N-acylhydrazone derivatives against Trichomonas vaginalis: in vitro and in silico analyses.
Alves MSD; das Neves RN; Sena-Lopes Â; Domingues M; Casaril AM; Segatto NV; Nogueira TCM; de Souza MVN; Savegnago L; Seixas FK; Collares T; Borsuk S
Parasit Vectors; 2020 Feb; 13(1):59. PubMed ID: 32046788
[TBL] [Abstract][Full Text] [Related]
10. 2-Methyl-4/5-nitroimidazole derivatives potentiated against sexually transmitted Trichomonas: Design, synthesis, biology and 3D-QSAR study.
Mandalapu D; Kushwaha B; Gupta S; Singh N; Shukla M; Kumar J; Tanpula DK; Sankhwar SN; Maikhuri JP; Siddiqi MI; Lal J; Gupta G; Sharma VL
Eur J Med Chem; 2016 Nov; 124():820-839. PubMed ID: 27643640
[TBL] [Abstract][Full Text] [Related]
11. Nanoliposomes increases Anti-Trichomonas vaginalis and apoptotic activities of metronidazole.
Ebrahimi M; Montazeri M; Ahmadi A; Nami S; Hamishehkar H; Shahrivar F; Bakhtiar NM; Nissapatorn V; Spotin A; Ahmadpour E
Acta Trop; 2021 Dec; 224():106156. PubMed ID: 34599888
[TBL] [Abstract][Full Text] [Related]
12. In vitro effect of octenidine dihydrochloride against Trichomonas vaginalis.
Küng E; Pietrzak J; Klaus C; Walochnik J
Int J Antimicrob Agents; 2016 Mar; 47(3):232-4. PubMed ID: 26899578
[TBL] [Abstract][Full Text] [Related]
13. Challenges and Persistent Questions in the Treatment of Trichomoniasis.
de Brum Vieira P; Tasca T; Secor WE
Curr Top Med Chem; 2017; 17(11):1249-1265. PubMed ID: 27697044
[TBL] [Abstract][Full Text] [Related]
14. Anti-Trichomonas vaginalis activity and chemical analysis of metabolites produced by marine-associated fungi.
Senger FR; Campos-Silva R; Landell MF; Silva DB; Menezes CB; Rigo GV; Silva LN; Trentin DS; Macedo AJ; Tasca T
Parasitol Res; 2022 Mar; 121(3):981-989. PubMed ID: 35113221
[TBL] [Abstract][Full Text] [Related]
15. Drug library screening against metronidazole-sensitive and metronidazole-resistant Trichomonas vaginalis isolates.
Goodhew EB; Secor WE
Sex Transm Infect; 2013 Sep; 89(6):479-84. PubMed ID: 23794105
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of amixicile against T. vaginalis from clinical isolates.
Jain E; Zaenker EI; Hoffman PS; Warren CA
Parasitol Res; 2022 Aug; 121(8):2453-2455. PubMed ID: 35676563
[TBL] [Abstract][Full Text] [Related]
17. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.
Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T
Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567
[TBL] [Abstract][Full Text] [Related]
18. Imidazole Carbamates as a Promising Alternative for Treating Trichomoniasis: In Vitro Effects on the Growth and Gene Expression of
Martínez-Rosas V; Navarrete-Vázquez G; Ortega-Cuellar D; Arreguin-Espinosa R; Pérez de la Cruz V; Calderón-Jaimes E; Enríquez-Flores S; Wong-Baeza C; Baeza-Ramírez I; Morales-Luna L; Vázquez-Bautista M; Rojas-Alarcón MA; Hernández-Ochoa B; Gómez-Manzo S
Molecules; 2024 May; 29(11):. PubMed ID: 38893461
[TBL] [Abstract][Full Text] [Related]
19. Drug repositioning for novel antitrichomonas from known antiprotozoan drugs using hierarchical screening.
Meneses-Marcel A; Marrero-Ponce Y; Ibáñez-Escribano A; Gómez-Barrio A; Escario JA; Barigye SJ; Terán E; García-Jacas CR; Machado-Tugores Y; Nogal-Ruiz JJ; Arán-Redó VJ
Future Med Chem; 2018 Apr; 10(8):863-878. PubMed ID: 29589477
[TBL] [Abstract][Full Text] [Related]
20. Triosephosphate isomerase as a therapeutic target against trichomoniasis.
Benítez-Cardoza CG; Brieba LG; Arroyo R; Rojo-Domínguez A; Vique-Sánchez JL
Mol Biochem Parasitol; 2021 Nov; 246():111413. PubMed ID: 34537286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
